Entact Bio Stock

Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.

Sign up today and learn more about Entact Bio Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Entact Bio Stock

Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed to create enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.

Funding History

December 2022$81.0M

Management

Board Member

Owen Smith

Board Member

Alon Lazarus

Board Member

Mara Macdonald

Board Member

Colin Walsh

Board Member

Victoria Richon

Board Member

Andrew Sinclair

Board Member

Richard Gaster

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo